[Stimulating glutamatergic neurons as a potential novel therapeutic avenue for schizophrenia].
Nakato
Kazuhiro
K
kazuhiro.nakato@jp.astellas.com
Harada
Katsuya
K
Tobe
Takahiko
T
Yamaji
Takayuki
T
Takakura
Shoji
S
D000818:Animals; D015195:Drug Design; D005971:Glutamates / Q000032:analysis*; D005998:Glycine / Q000378:metabolism; D006801:Humans; D009474:Neurons / Q000737:chemistry*; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors*; D012521:Sarcosine / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy*
D005971:Glutamates; D016194:Receptors, N-Methyl-D-Aspartate; D005998:Glycine; D012521:Sarcosine